[Skip navigation]FDA Logo links to FDA home page
Center for Drug Evaluation and Research, U.S. Food and Drug AdministrationU.S. Food and Drug AdministrationCenter for Drug Evaluation and Research
  HHS Logo links to Department of Health and Human Services website

FDA Home Page | CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER

horizonal rule
CDER Home About CDER Drug Information Regulatory Guidance CDER Calendar Specific Audiences CDER Archives
 
Powered by Google
 

Recall of Infliximab, Remicade


DATE RECALL INITIATED:

November 19, 2002

LOT NUMBERS / EXPIRATION DATES:

02F053A   7/2004
02F103A   8/2004

MANUFACTURER:

Centocor, Inc
Malvern, PA

REASON:

In response to customer complaints associated with lack of vacuum in the vial, the manufacturer found that the recalled products exhibit a stoppering defect that may contribute to the high incidence of this occurrence.


The information in this listing reflects CBER's best efforts to communicate information that has been reported to FDA. Its accuracy and comprehensiveness cannot be guaranteed.


Last Updated: 11/25/2002

 

Back to Top     Back to Index

Updated: September 26, 2003

horizonal rule